53.99

4.43% 2.298

Spruce Biosciences Inc (SPRB)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$51.69

Offen:

$56.75

24-Stunden-Volumen:

126.17K

Relative Volume:

2.27

Marktkapitalisierung:

$73.42M

Einnahmen:

$697.00K

Nettoeinkommen (Verlust:

$-38.97M

KGV:

-1.8569

EPS:

-29.075

Netto-Cashflow:

$-33.33M

1W Leistung:

-22.13%

1M Leistung:

-7.57%

6M Leistung:

-61.59%

1J Leistung:

-90.34%

1-Tages-Spanne:

$53.43

$56.75

1-Wochen-Bereich:

$51.36

$74.00

52-Wochen-Spanne:

$7.26

$543.38

Spruce Biosciences Inc Stock (SPRB) Company Profile

Firmenname

Spruce Biosciences Inc

Sektor

Healthcare (1113)

Branche

Biotechnology (624)

Telefon

(415) 655-4168

Adresse

611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-05

Neueste SEC-Einreichungen

SPRB's Discussions on Twitter

Compare SPRB vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SPRB Spruce Biosciences Inc	53.50	70.93M	697.00K	-38.97M	-33.33M	-29.07
VRTX Vertex Pharmaceuticals Inc	436.97	111.05B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	744.34	79.01B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	795.50	50.08B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	310.08	41.15B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	311.22	34.67B	5.36B	287.73M	924.18M	2.5229

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-23	Eingeleitet	Oppenheimer	Outperform
2025-12-03	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-10-28	Hochstufung	Citizens JMP	Mkt Perform → Mkt Outperform
2024-12-11	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2024-12-11	Herabstufung	Oppenheimer	Outperform → Perform
2024-03-14	Herabstufung	Guggenheim	Buy → Neutral
2024-03-14	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-03-14	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2024-03-14	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-03-14	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-02-21	Eingeleitet	Guggenheim	Buy
2021-12-17	Eingeleitet	Oppenheimer	Outperform
2021-12-10	Eingeleitet	The Benchmark Company	Speculative Buy
2021-11-16	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2021-07-19	Eingeleitet	H.C. Wainwright	Buy
2021-04-26	Fortgesetzt	Credit Suisse	Outperform
2020-11-03	Eingeleitet	Cowen	Outperform
2020-11-03	Eingeleitet	Credit Suisse	Outperform
2020-11-03	Eingeleitet	RBC Capital Mkts	Outperform
2020-11-03	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten

08:05 AM

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

08:05 AM

07:17 AM

SPRB Spruce Biosciences Inc. gains 3.53 percent even as Q4 2025 earnings miss analyst consensus estimates.Recovery Report - Xã Thanh Hà

07:17 AM

06:48 AM

Spruce Biosciences Prices Equity Offering to Raise Capital - TipRanks

06:48 AM

06:03 AM

Spruce Biosciences Enters Underwriting For $69 Million Equity Offering; Option Fully Exercised - TradingView

06:03 AM

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50.00 per share - MSN

Apr 21, 2026

Spruce Biosciences (NASDAQ: SPRB) raises about $69.0 million in equity sale - Stock Titan

Apr 21, 2026

Spruce Biosciences (NASDAQ: SPRB) sells 1.15M shares, issues pre-funded warrants - Stock Titan

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50 per share By Investing.com - Investing.com South Africa

Apr 21, 2026

Stock Market Today: Dow Jones, S&P 500 Futures Edge Higher With Eyes On Iran Talks—Apple, UnitedHealth, 3M In Focus - Benzinga

Apr 21, 2026

Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 21, 2026

Spruce Biosciences locks in $60M raise at $50 a share - Stock Titan

Apr 21, 2026

Spruce Biosciences Prices Public Offering of Common Stock, Prefunded Warrants>SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences (SPRB) Announces $60 Million Public Offering - GuruFocus

Apr 21, 2026

Spruce Biosciences Offering Expected to Close April 22 >SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences launches public stock offering By Investing.com - Investing.com India

Apr 21, 2026

Spruce Biosciences Expects Gross Proceeds of $60M >SPRB - Moomoo

Apr 21, 2026

Spruce Biosciences prices $60M public offering at $50 per share - Investing.com Canada

Apr 21, 2026

Apr 20, 2026

Spruce Biosciences Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants - TradingView

Apr 20, 2026

Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours - Moomoo

Apr 20, 2026

Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The National Law Review

Apr 20, 2026

Spruce Biosciences announces proposed public offering of common stock, pre-funded warrants - MSN

Apr 20, 2026

Spruce Biosciences (SPRB) Sees 13% Drop Following Equity Offerin - GuruFocus

Apr 20, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 20, 2026

Spruce Biosciences launches public stock offering - Investing.com

Apr 20, 2026

Spruce Biosciences Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants - TradingView

Apr 20, 2026

Spruce Biosciences (SPRB) seeks capital with common stock and pre-funded warrants offering - Stock Titan

Apr 20, 2026

Apr 16, 2026

SPRB Technical Analysis | Trend, Signals & Chart Patterns | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

Apr 16, 2026

Apr 10, 2026

Top Anthem (ANTX) Competitors 2026 - MarketBeat

Apr 10, 2026

SPRB Stock Price, Quote & Chart | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

Apr 10, 2026

Apr 09, 2026

Spruce Biosciences (NASDAQ: SPRB) sets 2026 virtual meeting and pay votes - Stock Titan

Apr 09, 2026

Apr 08, 2026

SPRB SEC FilingsSpruce Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 08, 2026

Apr 03, 2026